Inebilizumab Biosimilar - Research Grade

Inebilizumab Biosimilar - Research Grade

Product Benefits:

ichorbio’s Inebilizumab Biosimilar for Research Use Only (RUO). ichorbio's inebilizumab biosimilar is not afucosylated.

Target:

CD19

Size:

ichorbio’s Inebilizumab Biosimilar is available in the following sizes: 1mg, 5mg, 10mg, 20mg, 50mg, 100mg

Isotype:

Human IgG1(K214R)-Kappa

Host:

CHO Cells

Species Reactivity:

Human

Specificity:

Detects human CD19.

Purification Method:

This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Concentration:

5mg/ml

Sterile, preservative-free, solution in PBS. BSA and Azide free.

>95% by SDS-PAGE

≤ 1.0 EU/mg as determined by the LAL method

This antibody is stable for at least 4 weeks when stored at 2-8°C. For long term storage, aliquot in working volumes without diluting and store at – 20°C or -80°C. Avoid repeated freeze thaw cycles.

Functional Assays

This biosimilar is strictly for research use only (RUO).